Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults
Abstract Fifteen years after its licensure, this revision assesses the role of cefditoren facing the current pharmacoepidemiology of resistances in respiratory human-adapted pathogens (Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis). In the era of...
Үндсэн зохиолчид: | María-José Giménez, Lorenzo Aguilar, Juan José Granizo |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Mattioli 1885
2018-11-01
|
Цуврал: | Multidisciplinary Respiratory Medicine |
Онлайн хандалт: | http://link.springer.com/article/10.1186/s40248-018-0152-5 |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Cefditoren in upper and lower community-acquired respiratory tract infections
-н: Francisco Soriano, зэрэг
Хэвлэсэн: (2011-02-01) -
CEFDITOREN IN THE TREATMENT OF PURULENT RINOSINUSITIS
-н: G. N. Nikiforova, зэрэг
Хэвлэсэн: (2017-11-01) -
Update on the clinical utility and optimal use of cefditoren
-н: Barberán J, зэрэг
Хэвлэсэн: (2012-05-01) -
ANTIBACTERIAL THERAPY OF ACUTE RINOSINUSITIS BY CEFDITOREN
-н: S. V. Ryazantsev, зэрэг
Хэвлэсэн: (2017-05-01) -
High protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulation.
-н: David Sevillano, зэрэг
Хэвлэсэн: (2008-01-01)